CD8A and rheumatoid arthritis: A strength of the paper is the deeper characterization of the spike and nonspike‐specific Treg and their unique phenotype in SARS‐CoV‐2 RA vaccine recipients, as well as the description of a CD4−CD8− DN T cell population that differentiated into CD8+ T cells in the periphery.